The Gastric Bypass Stent System as a Treatment for Hepatic Fibrosis in Obese Patients in European Region
Recruiting now · Not applicable
Conditions studied: Fibrosis, Liver
In brief
The Gastric Bypass Stent System is intended to be used in weight loss treatment for obesity and holds potential as a non-invasive technique for managing hepatic fibrosis. This pilot, prospective, single-arm, clinical investigation aims to evaluate the safety and performance of the Gastric Bypass Stent System for hepatic fibrosis treatment in Europe. This clinical investigation and the ongoing clinical investigation (Protocol number: BL-RD08-040) will be used to evaluate the safety and performance of the investigational device for the intended use.
Key facts
- Study ID
- NCT06561529
- Run by
- MDCECRO LLC
- People needed
- 10
- Starts
- 2024-06-13
- Expected to finish
- 2025-12-01
- Last updated by the study team
- 2025-05-08
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
Where it is running
- REUH, hospital "lnfectology center of Latvia" — Riga, Riga, Latvia (enrolling)
- Digestive Diseases Centre "GASTRO" — Riga, Latvia (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.